Histopathological observations in the brains of children exposed to inhalational anesthetic agents: a retrospective autopsy-based study.

BACKGROUND: Numerous animal models have demonstrated neuronal damage resulting from anesthetic exposure in the developing brain. Studies have shown a relationship between anesthetic exposure and brain hypoxia, neurodegeneration and apoptosis. The relevance of data derived from controlled experimental studies to human neuropathology is a subject of debate. This study compares histopathological findings in post-mortem brain tissue specimens from children with and without exposure to inhalational anesthetic agents. METHODS: Autopsy reports were reviewed. Patients were divided into exposure and non-exposure groups defined as any procedure involving inhalational anesthetic agents. A retrospective chart review was performed collecting pathological findings of the brain. The autopsy results examined the presence of twelve different histopathological parameters reflecting morphologic changes in thirteen regions of interest in the central nervous system. RESULTS: Post-mortem neuropathological findings were analyzed. Thirteen different areas were focused upon and changes were categorized into twelve histopathological parameters. Gliosis, which was confirmed by immunohistochemical staining for glial fibrillary acidic protein, was more prevalent in the exposure group (N.=48) compared to the non-exposure group (N.=20) (P<0.05). CONCLUSION: The role of anesthetic neurotoxicity is not well understood. Numerous animal models have demonstrated neuronal apoptotic changes linked to anesthetic exposure, there is no tangible evidence supporting this relationship in humans. Our analysis demonstrates histopathological brain changes in children with anesthetic exposure not seen in the non-exposed group. Analysis was based on histopathological parameters representative of salient morphological findings of injury, which were encountered in anatomically divergent regions. Gliosis was the only statistically significant finding in post-mortem brain samples of patients who had received anesthetics.

A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease.

INTRODUCTION: This study was conducted to compare the genotype and markers of disease severity of chronic hepatitis C (CHC), namely viral load, alanine transaminase (ALT) levels and histopathological findings on liver biopsy, in patients with and without end-stage renal disease (ESRD). METHODS: This was a cross-sectional retrospective comparative study that included ESRD patients on haemodialysis and non-ESRD patients with CHC who underwent liver biopsy between January 2004 and December 2006. Blood tests for viral load (VL) (hepatitis C virus, ribonucleic acid, polymerase chain reaction), genotyping and ALT were administered. VL was grouped into low (less than 5 log10) and high (more than or equal to 5 log10) VL, genotype into G1 and 2, 3, 4, and ALT into normal and elevated ALT. Necroinflammatory activity was grouped into mild (G0-6) and moderate/severe (G7-18) activity, and fibrosis into mild (S0-2) and moderate/severe (S3-6) fibrosis. These variables were compared between the two groups. RESULTS: Genotype 1 was significantly higher in ESRD patients than in non-ESRD patients, in whom genotypes 2, 3 and 4 were higher. Although the proportion of patients with high VL was greater and the duration of CHC was longer in the ESRD group, the ALT levels were lower and the histopathological grading of necroinflammatory activity and stages of fibrosis were less severe in ESRD compared to non-ESRD patients. CONCLUSION: The lower levels of ALT observed in CHC patients with ESRD translate to histopathological benefits.

Venipuncture versus heel prick for blood glucose monitoring in neonates.

INTRODUCTION: The aim of this study was to determine whether there was a difference in the pain indicators and effectiveness between venipuncture (VP) and heel prick (HP) for blood glucose monitoring in term neonates (recently, venipuncture was shown superior for the Guthrie test). METHODS: 66 term neonates undergoing blood glucose monitoring underwent VP or HP. Primary outcome measures included the Neonatal Facial Scoring System (NFCS) score, duration of the first cry, total duration of cry and duration of procedure. Secondary outcome measured was the number of skin punctures needed to obtain blood. RESULTS: The NFCS score was not significantly different between the two groups and the duration of the procedure was significantly longer for the VP than the HP group (median 27 s vs. 7 s; p-value is less than 0.001). The differences between the two groups in the duration of the first cry, total duration of cry and number of skin punctures needed to obtain blood were not statistically significant, but these parameters displayed a trend, favouring the HP. CONCLUSION: The HP is still the preferred method of drawing blood in neonates for blood glucose monitoring, as only one drop of blood is required.

Prognostic factors of differentiated thyroid cancer patients in Hospital Universiti Sains Malaysia.

INTRODUCTION: The aim of this study was to identify the prognostic factors that influence the survival of differentiated thyroid cancer patients treated at Hospital Universiti Sains Malaysia (HUSM). METHODS: A total of 178 patients diagnosed with and treated for differentiated thyroid cancer in HUSM between January 1974 and July 2003 were included in this retrospective cohort study. The additional follow-up period was one year after the end of the recruitment phase. The data was collected from the medical records of the patients. RESULTS: The overall five- and ten-year relative survivals of differentiated thyroid cancer patients in HUSM were 90.6 percent (95 percent confidence interval [CI] 84.4-94.4) and 85.3 percent (95 percent CI 76.0-91.2), respectively. The significant prognostic factors for differentiated thyroid cancer were age (hazard ratio [HR] 6.9; 95 percent CI 1.7-28.6), loss of appetite (HR 10.9; 95 percent CI 2.7-43.7), tumour size (HR 3.7; 95 percent CI 1.1-13.8), regional recurrences (HR 3.2; 95 percent CI 1.1-9.8), high-risk stage (HR 19.9; 95 percent CI 4.4-90.4), and treatment (HR 0.2; 95 percent CI: 0.1-0.5). CONCLUSION: The survival rates obtained in this study were slightly lower than other studies but the pattern of survival rates between groups were similar. Prognostic factors identified in this study were similar to those of other studies, suggesting that the experience of HUSM was almost similar with that of other institutions.